U.S. Food & Drug Administration (FDA) FDA-TRACK Update

FDA-TRACK is an agency-wide performance management system that monitors over 100 FDA program offices through key performance measures and projects.  These measures are reported monthly and updated quarterly on the website.
What's New with FDA-TRACK
December 2012 Performance Data Updates
New performance data are available for the dashboards below.
Cross Agency

• FDA-TRACK Health Care Reform (ACA) Dashboard
• October 15, 2012: FDA-TRACK Medical Countermeasures Initiative (MCMi) Quarterly Briefing Summary 
• FDA-TRACK Medical Countermeasures Initiative (MCMi) Dashboard – The Center for Drug Evaluation and Research (CDER) completed development of an animal model to model absorption and distribution of an administered drug, the rate at which a drug action begins and the duration of its effect in developing nonhuman primate as part of its “Animal Models of Pregnancy to Address Medical Countermeasures” key project. 

National Center for Toxicological Research (NCTR)

   

• October 15, 2012: FDA-TRACK NCTR Quarterly Briefing Summary
• FDA-TRACK NCTR Dashboard - As part of DBT’s program measure, “Quantitative Assessments of Acrylamide and Furan”, a manuscript describing the tumorigenicity of acrylamide and glycidamide in newborn mice was recently published in the International Journal of Cancer. DM completed its “Alternative Approaches to Antibiotic Therapy for the Prevention and Treatment of Bacterial Infections” project and a manuscript is under review. As part of DM’s program measure, “Impact of Antimicrobial Drug Residues on Human Gastrointestinal Microorganisms”, manuscripts describing the work have been published in the Journal of Antibiotics, Anaerobe and the Journal of Regulatory Toxicology and Pharmacology.

Office of the Commissioner (OC)

• October 15, 2012: FDA-TRACK Office of the Chief Scientist Quarterly Briefing Summary
• FDA-TRACK OC Office of the Chief Scientist (OCS) Dashboard – ORSI added new key projects to track progress of the Centers of Excellence in Regulatory Science and Innovation (CERSI) program, Broad Agency Announcement (BAA), and FDA Nanotechnology Regulatory Science Program. OWH completed its key project to launch a Video Novella named “Nunca Mas” in an effort to minimize consumer medication risks and reduce preventable harm from medications in underserved Hispanic audiences.

  

January 2013 Upcoming Performance Data Updates

The below listed programs are expected to publish performance data updates in January 2013. Updates are posted to each dashboard approximately 30 business days after each quarterly briefing with FDA senior leadership.

• Advisory Committees
• Center for Biologics Evaluation & Research (CBER)
• Center for Devices and Radiological Health (CDRH)
• Center for Food Safety and Applied Nutrition (CFSAN)
• Center for Tobacco Products (CTP)
• Center for Veterinary Medicine (CVM)
• Freedom of Information Act (FOIA)
• Office of International Programs (OIP)
• Office of Operations
• Office of Regulatory Affairs (ORA)
• Office of Special Medical Programs (OSMP)
• Office of the Commissioner – Office of Policy and Planning
• Office of the Commissioner – Other Offices

  

General Program Updates

• Quarterly Briefing Summaries – Visit this page for public summaries of accomplishments discussed at each FDA-TRACK briefing. We post summaries approximately 30 business days after each quarterly briefing, along with updated performance measures and results. This page includes a new summary for MCMi, NCTR, and OCS.
• Completed Key Projects – Visit this page to read about completed key projects to date. New additions include NCTR and OCS.